Cover Image

Tumor-associated CD19$^+$ macrophages induce immunosuppressive microenvironment in hepatocellular carcinoma

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Wang, Junli, Cao, Wanyue, Huang, Jinyan, Zhou, Yu, Zheng, Rujia, Lou, Yu, Yang, Jiaqi, Tang, Jianghui, Ye, Mao, Hong, Zhengtao, Wu, Jiangchao, Ding, Haonan, Zhang, Yuquan, Sheng, Jianpeng, Lu, Xinjiang, Xu, Pinglong, Lu, Xiongbin, Bai, Xueli, Liang, Tingbo, Zhang, Qi
Format:	Preprint
Published:	2025
Subjects:	Cell Behavior
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CHD6 drives an immunosuppressive vascular ecotype and therapy resistance in hepatocellular carcinoma
by: Fan, Xutong, et al.
Published: (2026)

M2 tumor–associated macrophages and CXCL2 induce lipid remodeling in hepatocellular carcinoma cell lines
by: Yongling Chen, et al.
Published: (2024)

Harnessing nanomaterials to precisely regulate the immunosuppressive tumor microenvironment for enhanced immunotherapy
by: Wen Zhang, et al.
Published: (2025)

Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma
by: Jun Yang, et al.
Published: (2024)

LC–MS/MS method for the quantification of cortisol of hepatocellular carcinoma
by: Zijing Zhou, et al.
Published: (2024)

NPC1 promotes the progression of hepatocellular carcinoma by mediating the accumulation of neutrophils into the tumor microenvironment
by: Songhai Yang, et al.
Published: (2024)

Comprehensively analysis of IL33 in hepatocellular carcinoma prognosis, immune microenvironment and biological role
by: Lifang Wei, et al.
Published: (2024)

Exploring the interplay between bisphenol A exposure, the immune microenvironment and hepatocellular carcinoma progression
by: Qi Liu, et al.
Published: (2024)

Proteogenomic characterisation of primary oral cancer unveils extracellular matrix remodelling and immunosuppressive microenvironment linked to lymph node metastasis
by: Yu Liu, et al.
Published: (2025)

RETRACTED: Prognostic value and potential mechanism of cellular senescence and tumor microenvironment in hepatocellular carcinoma: Insights from bulk transcriptomics and single‐cell sequencing analysis
by: Chang Qu, et al.
Published: (2024)

miR‐34a promotes the immunosuppressive function of multiple myeloma‐associated macrophages by dampening the TLR‐9 signaling
by: Rui Zhang, et al.
Published: (2024)

Spatial transcriptomics deciphers the immunosuppressive microenvironment in colorectal cancer with tumour thrombus
by: Heming Ge, et al.
Published: (2024)

Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy
by: Yongqing Qin, et al.
Published: (2024)

Hepatoid adenocarcinoma of the lung mimicking metastatic hepatocellular carcinoma
by: Yu Miyama
Published: (2020)

Hepatitis B virus‐related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures
by: Yuanjie Liu, et al.
Published: (2024)

Identification of hypoxic macrophages in glioblastoma: Unveiling therapeutic insights from tumour microenvironment analysis
by: Zhen Qin, et al.
Published: (2024)

Baseline vitamin D status, genetic susceptibility, and the risk of incident hepatocellular carcinoma
by: Chengxiao Yu, et al.
Published: (2025)

The influence of microbiome‐derived amino acids metabolites in shaping the glioma immunosuppressive microenvironment
by: Qianquan Ma, et al.
Published: (2025)

Tumor‐infiltrating B cells participate in shaping the immunosuppressive microenvironment in solid tumors
by: Zhitong Li, et al.
Published: (2025)

Targeting CLEC4E in immunosuppressive tumour‐associated macrophages via BET inhibition
by: Mengting Liao, et al.
Published: (2025)

Multifaceted role of FAM210B in hepatocellular carcinoma: Implications for tumour progression, microenvironment modulation and therapeutic selection
by: Xianzhu Pan, et al.
Published: (2024)

Role of the ubiquitin–proteasome system on macrophages in the tumor microenvironment
by: Yue Xiao, et al.
Published: (2024)

Single‐cell profiling reveals the metastasis‐associated immune signature of hepatocellular carcinoma
by: Deyuan Zhong, et al.
Published: (2024)

Host ANGPTL2 establishes an immunosuppressive tumor microenvironment and resistance to immune checkpoint therapy
by: Shinsei Yumoto, et al.
Published: (2024)

Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
by: Shiqi Li, et al.
Published: (2024)

MRI for hepatocellular carcinoma and the role of abbreviated MRI for surveillance of hepatocellular carcinoma
by: Soe Thiha Maung, et al.
Published: (2024)

RETRACTED: A bibliometric analysis of global research on microbial immune microenvironment in melanoma from 2012 to 2022
by: Lin Sun, et al.
Published: (2024)

Methylation in hepatocellular carcinoma
by: REGINA M. SANTELLA
Published: (2007)

Epidemiology of hepatocellular carcinoma
by: RAYMUNDO PARANÁ
Published: (2007)

LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2‐macrophage infiltration through activating AKT‐IKKβ‐p65 axis
by: Banglun Pan, et al.
Published: (2024)

Vascular endothelial growth factor released from lenvatinib‐resistant hepatocellular carcinoma promotes malignant behavior and drug resistance through tumor‐associated macrophages
by: Yukako Takehara, et al.
Published: (2025)

PRMT1‐mediated arginine methylation promotes YAP activation and hepatocellular carcinoma proliferation
by: Jian Yu, et al.
Published: (2024)

Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma
by: Shuai Yang, et al.
Published: (2024)

Back Cover: Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma (EXP2 2/2025)
by: Jun Yang, et al.
Published: (2025)

The cumulative antitumor effects of regorafenib and radiotherapy in hepatocellular carcinoma
by: Shuwen Kuang, et al.
Published: (2024)

Role of ACSL4 in modulating farnesoid X receptor expression and M2 macrophage polarization in HBV‐induced hepatocellular carcinoma
by: Wenbiao Chen, et al.
Published: (2024)

Plasma metabolomic profiling for hepatocellular carcinoma diagnosis and microvascular invasion prediction
by: Fei Huang, et al.
Published: (2025)

Establishment of an in situ model to explore the tumor immune microenvironment in head and neck squamous cell carcinoma
by: Congxian Lu, et al.
Published: (2024)

Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives
by: Jian‐Jian Chen, et al.
Published: (2024)

An inflammatory liquid fingerprint predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
by: Modan Yang, et al.
Published: (2024)